Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Les pH des selles des nourrissons sains et malades.Nourrisson. 1931; 19: 147-153
- Measurement of gastrointestinal pH profiles in normal ambulant human subjects.Gut. 1988; 29: 1035-1041
- Observations on the etiologic relationship of achylia gastrica to pernicious anemia; activity of vitamin B12 as food, extrinsic factor.N Engl J Med. 1948; 239: 911-913
- Intraluminal pH of the human gastrointestinal tract.Dan Med Bull. 1999; 46: 183-196
- Biotin transport in the human intestine: site of maximum transport and effect of pH.Gastroenterology. 1988; 95: 1312-1317
- Enzymatic reduction and methylation of folate following pH-dependent, carrier-mediated transport in rat jejunum.Biochim Biophys Acta. 1979; 554: 249-257
- Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.JAMA. 2013; 310: 2435-2442
- Vitamin B12 uptake by human small bowel homogenate and its enhancement by intrinsic factor.Gastroenterology. 1969; 56: 548-555
- Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management.7th edition. Saunders, Philadelphia2002
- Analysis of the membrane domain of the gastric H(+)/K(+)-ATPase.J Exp Biol. 2000; 203: 161-170
- Proton pump inhibitors: a balanced view.Karger AG, Basel (Switzerland)2013
- Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats.Gastroenterology. 1986; 90: 391-399
- A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole.Nat Rev Drug Discov. 2003; 2: 132-139
- A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.Clin Pharmacol Ther. 2006; 79: 103-113
- American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease.Gastroenterology. 2008; 135 (1391.e1–5): 1383-1391
- The gastric HK-ATPase: structure, function, and inhibition.Pflugers Arch. 2009; 457: 609-622
- Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers.Gastroenterology. 2008; 134: 1836-1841
- Effect of omeprazole 40 mg once daily on intraduodenal and intragastric pH in H. pylori-negative healthy subjects.Dig Dis Sci. 1997; 42: 2304-2309
- Impact of acid suppression on upper gastrointestinal pH and motility.Dig Dis Sci. 2011; 56: 1735-1742
IMS Health. Top-Line Market Data. Available at: http://www.imshealth.com/portal/site/ims/menuitem.5ad1c081663fdf9b41d84b903208c22a/?vgnextoid=fbc65890d33ee210VgnVCM10000071812ca2RCRD. Accessed March 23, 2014.
- Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected].Am J Gastroenterol. 2009; 104: S27-S32
- Long-term use of acid suppression started inappropriately during hospitalization.Aliment Pharmacol Ther. 2005; 21: 1203-1209
- Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database.BMJ. 1998; 317: 452-456
- Safety of proton pump inhibitor exposure.Gastroenterology. 2010; 139: 1115-1127
- Proton-pump inhibitors and hypomagnesemic hypoparathyroidism.N Engl J Med. 2006; 355: 1834-1836
- The association of proton pump inhibitors and hypomagnesemia in the community setting.J Clin Pharmacol. 2014; 54: 889-895
- The effect of proton pump inhibitors on the human microbiota.Curr Drug Metab. 2009; 10: 84-89
- Properties and function of the P type ion pumps cloned from Helicobacter pylori.Acta Physiol Scand Suppl. 1998; 643: 123-135
- Genome of the bacterium Streptococcus pneumoniae strain R6.J Bacteriol. 2001; 183: 5709-5717
- Guidelines for the diagnosis and management of gastroesophageal reflux disease.Am J Gastroenterol. 2013; 108 ([quiz: 329]): 308-328
- American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease.Gastroenterology. 2008; 135 (1413.e1–5): 1392-1413
- ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).Am J Gastroenterol. 2013; 108 ([quiz: 693]): 679-692
- Time trends of gastroesophageal reflux disease: a systematic review.Clin Gastroenterol Hepatol. 2007; 5: 17-26
- The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.J Natl Cancer Inst. 2005; 97: 142-146
- Who is using chronic acid suppression therapy and why?.Am J Gastroenterol. 2003; 98: 51-58
- Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome.Gastroenterology. 2009; 137: 588-597
- Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.Clin Cancer Res. 2012; 18: 2138-2144
- Inducible and neuronal nitric oxide synthase involvement in lipopolysaccharide-induced sphincteric dysfunction.Am J Physiol Gastrointest Liver Physiol. 2001; 280: G32-G42
- Downregulation of nNOS and synthesis of PGs associated with endotoxin-induced delay in gastric emptying.Am J Physiol Gastrointest Liver Physiol. 2002; 283: G1360-G1367
- Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett's esophagus.BMC Infect Dis. 2013; 13: 130
- Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors.Environ Microbiol. 2013; https://doi.org/10.1111/1462-2920.12285
- Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome.Gastroenterology. 2011; 141: 1792-1801
- Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis.Am J Gastroenterol. 2009; 104 ([quiz: 491, 501]): 492-500
- Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis.Clin Gastroenterol Hepatol. 2007; 5 (1417.e1–2): 1413-1417
- Association between Helicobacter pylori and Barrett's esophagus: a case-control study.Am J Gastroenterol. 2014; 109: 357-368
- Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.Antimicrob Agents Chemother. 1991; 35: 490-496
- American College of Gastroenterology guideline on the management of Helicobacter pylori infection.Am J Gastroenterol. 2007; 102: 1808-1825
- Comparative analysis of human gut microbiota by barcoded pyrosequencing.PLoS One. 2008; 3: e2836
- Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa.Aliment Pharmacol Ther. 2001; 15: 379-388
- Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer.Gastroenterology. 1996; 110: 725-732
- Helicobacter pylori and the gastric microbiota.Best Pract Res Clin Gastroenterol. 2013; 27: 39-45
- Digestive tract microbiota in healthy volunteers.Clinics (Sao Paulo). 2007; 62: 47-54
- Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use.PLoS One. 2009; 4: e7985
- Helicobacter pylori in health and disease.Gastroenterology. 2009; 136: 1863-1873
- Drug-induced hypochlorhydria causes high duodenal bacterial counts in the elderly.Aliment Pharmacol Ther. 1998; 12: 99-104
- Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers.Gastroenterology. 2005; 128: 1567-1578
- IARC working group on the evaluation of carcinogenic risks to humans: some industrial chemicals. Lyon, 15-22 February 1994.IARC Monogr Eval Carcinog Risks Hum. 1994; 60: 1-560
- Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.JAMA. 2004; 291: 187-194
- Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality.J Natl Cancer Inst. 2012; 104: 488-492
- Management of Helicobacter pylori infection–the Maastricht IV/Florence Consensus Report.Gut. 2012; 61: 646-664
- Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection.J Dig Dis. 2013; 14: 211-221
- Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls.J Med Microbiol. 2009; 58: 509-516
- Chronic Helicobacter pylori infection does not significantly alter the microbiota of the murine stomach.Appl Environ Microbiol. 2007; 73: 1010-1013
- Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer.Gastroenterology. 2000; 118: 36-47
- Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia.Gastroenterology. 2011; 140: 210-220
- Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis.Gut. 2014; 63: 54-63
- Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.Gastroenterology. 2000; 118: 661-669
- Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.Clin Gastroenterol Hepatol. 2010; 8: 504-508
- The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.Dig Dis Sci. 2012; 57: 1321-1329
- Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.Clin Gastroenterol Hepatol. 2013; 11: 483-490
- Small intestinal bacterial overgrowth syndrome.World J Gastroenterol. 2010; 16: 2978-2990
- Review article: proton pump inhibitors and bacterial overgrowth.Aliment Pharmacol Ther. 2006; 23: 3-10
- Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.Gastroenterology. 2011; 141 (1322.e1–5): 1314-1322
- Imbalance in the composition of the duodenal microbiota of children with coeliac disease.J Med Microbiol. 2007; 56: 1669-1674
- Use of proton pump inhibitors and subsequent risk of celiac disease.Dig Liver Dis. 2014; 46: 36-40
- Decreased risk of celiac disease in patients with Helicobacter pylori colonization.Am J Epidemiol. 2013; 178: 1721-1730
- Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses.Gut. 2008; 57: 1375-1385
- The human gut microbiome: ecology and recent evolutionary changes.Annu Rev Microbiol. 2011; 65: 411-429
- Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection.Cell. 2006; 127: 423-433
- Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.Am J Gastroenterol. 2012; 107: 1011-1019
- Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.Am J Gastroenterol. 2012; 107: 1001-1010
- Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.JAMA. 2005; 294: 2989-2995
- Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.CMAJ. 2006; 175: 745-748
- Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.CMAJ. 2004; 171: 33-38
- Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.J Crit Care. 2014; 29: 696.e11-696.e15
- Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.JAMA Intern Med. 2013; 173: 1359-1367
- In vitro killing of nosocomial pathogens by acid and acidified nitrite.Antimicrob Agents Chemother. 2006; 50: 3901-3904
- Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster.J Infect Dis. 1985; 151: 355-361
- Clostridium difficile–more difficult than ever.N Engl J Med. 2008; 359: 1932-1940
- Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge.J Clin Microbiol. 2005; 43: 5588-5592
- Is use of PPIs related to increased intraepithelial lymphocytes in the colon?.Dig Dis Sci. 2012; 57: 2669-2674
- Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity.Eur J Gastroenterol Hepatol. 2003; 15 ([author reply: 574]): 573-574
- Active potassium transport across guinea-pig distal colon: action of secretagogues.J Physiol. 1996; 493: 485-502
- Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.Am J Gastroenterol. 2013; 108: 1794-1801
- Proton pump inhibitors and risk for recurrent Clostridium difficile infection.Arch Intern Med. 2010; 170: 772-778
- Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease.J Infect Dis. 2010; 202: 1877-1884
- Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection.Microbiome. 2013; 1: 18
- Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome.PLoS One. 2010; 5: e9836
- Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs.FEMS Microbiol Ecol. 2012; 80: 624-636
- Gastric acid reduction leads to an alteration in lower intestinal microflora.Biochem Biophys Res Commun. 2009; 381: 666-670
Article info
Publication history
Published online: September 25, 2014
Footnotes
Funding: D.E. Freedberg was supported in part by National Institutes of Health training grants (T32 DK083256 and UL1 RR024156); B. Lebwohl was supported in part by The National Center for Advancing Translational Sciences, NIH (UL1 TR000040) and the American Gastroenterological Association Research Scholar Award; J.A. Abrams was supported in part by Columbia University's Irving Scholar Award and an NIH grant (U54 CA 163004).
Financial Disclosures: The authors have nothing to disclose.
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
